Retacrit® Epoetin Alfa-epbx 40,000 U/mL Injection for Anemia Treatment

Name: Retacrit® Epoetin Alfa-epbx 40,000 U/mL Injection for Anemia Treatment
Brand: Pfizer Biosimilar
SKU: USAMP#12465307
Price: 3025.83 USD
Availability: InStock

USAMP#12465307SKU: 00069130904Retacrit®

License Required

Product Spotlight

High-potency Retacrit® Epoetin Alfa-epbx 40,000 U/mL Injection for effective anemia management.
Single-dose 1 mL vial designed for ease of use and minimal waste.
Manufactured by Pfizer Biosimilar, ensuring pharmaceutical quality and reliability.
Formulated for subcutaneous or intravenous administration, providing flexibility in clinical application.
Requires refrigeration to maintain stability and efficacy of the medication.
Latex-free packaging to minimize allergic reactions and ensure patient safety.
An essential hematopoietic agent for patients with chronic kidney disease, chemotherapy-induced anemia, or HIV-related anemia.

Product Spotlight

High-potency Retacrit® Epoetin Alfa-epbx 40,000 U/mL Injection for effective anemia management.
Single-dose 1 mL vial designed for ease of use and minimal waste.
Manufactured by Pfizer Biosimilar, ensuring pharmaceutical quality and reliability.
Formulated for subcutaneous or intravenous administration, providing flexibility in clinical application.
Requires refrigeration to maintain stability and efficacy of the medication.
Latex-free packaging to minimize allergic reactions and ensure patient safety.
An essential hematopoietic agent for patients with chronic kidney disease, chemotherapy-induced anemia, or HIV-related anemia.